Jan Eriksson

Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR)

Fagher, Katarina; Eeg-Olofsson, Katarina; Arnqvist, Hans; Bolinder, Jan et al.

Ingår i Diabetologia, s. 50-58, 2026

• DOI för Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR)
• Ladda ner fulltext (pdf) av Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR)

SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications

Eriksson, Jan W; Fanni, Giovanni; Lundqvist, Martin H.; Jansson, Stefan P. O. et al.

Ingår i Diabetes, obesity and metabolism, s. 1327-1338, 2026

• DOI för SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications
• Ladda ner fulltext (pdf) av SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications

Role of FKBP5 in adipose tissue function: Implications for obesity and insulin sensitivity

Laterveer, Rutger; Hetty, Susanne; Mathioudaki, Argyri; Lundqvist, Martin H. et al.

Ingår i Molecular and Cellular Endocrinology, 2026

• DOI för Role of FKBP5 in adipose tissue function: Implications for obesity and insulin sensitivity
• Ladda ner fulltext (pdf) av Role of FKBP5 in adipose tissue function: Implications for obesity and insulin sensitivity

Effects of cafeteria diet and caloric restriction on pituitary hormones and metabolic phenotype in male Wistar rats

Kagios, Christakis; Hetty, Susanne; Hukema, Fleur W.; Fanni, Giovanni et al.

Ingår i Endocrine, s. 1459-1471, 2025

• DOI för Effects of cafeteria diet and caloric restriction on pituitary hormones and metabolic phenotype in male Wistar rats
• Ladda ner fulltext (pdf) av Effects of cafeteria diet and caloric restriction on pituitary hormones and metabolic phenotype in male Wistar rats

Cafeteria diet and caloric restriction affect metabolic but not behavioral characteristics in male Wistar rats

Kagios, Christakis; Hetty, Susanne; Grönbladh, Alfhild; Pereira, Maria J. et al.

Ingår i Physiology and Behavior, 2025

• DOI för Cafeteria diet and caloric restriction affect metabolic but not behavioral characteristics in male Wistar rats
• Ladda ner fulltext (pdf) av Cafeteria diet and caloric restriction affect metabolic but not behavioral characteristics in male Wistar rats

Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR)

Fagher, Katarina; Eeg-Olofsson, Katarina; Arnqvist, Hans; Bolinder, Jan et al.

Ingår i Diabetologia, s. 50-58, 2026

• DOI för Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR)
• Ladda ner fulltext (pdf) av Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR)

SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications

Eriksson, Jan W; Fanni, Giovanni; Lundqvist, Martin H.; Jansson, Stefan P. O. et al.

Ingår i Diabetes, obesity and metabolism, s. 1327-1338, 2026

• DOI för SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications
• Ladda ner fulltext (pdf) av SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications

Role of FKBP5 in adipose tissue function: Implications for obesity and insulin sensitivity

Laterveer, Rutger; Hetty, Susanne; Mathioudaki, Argyri; Lundqvist, Martin H. et al.

Ingår i Molecular and Cellular Endocrinology, 2026

• DOI för Role of FKBP5 in adipose tissue function: Implications for obesity and insulin sensitivity
• Ladda ner fulltext (pdf) av Role of FKBP5 in adipose tissue function: Implications for obesity and insulin sensitivity

Effects of cafeteria diet and caloric restriction on pituitary hormones and metabolic phenotype in male Wistar rats

Kagios, Christakis; Hetty, Susanne; Hukema, Fleur W.; Fanni, Giovanni et al.

Ingår i Endocrine, s. 1459-1471, 2025

• DOI för Effects of cafeteria diet and caloric restriction on pituitary hormones and metabolic phenotype in male Wistar rats
• Ladda ner fulltext (pdf) av Effects of cafeteria diet and caloric restriction on pituitary hormones and metabolic phenotype in male Wistar rats

Cafeteria diet and caloric restriction affect metabolic but not behavioral characteristics in male Wistar rats

Kagios, Christakis; Hetty, Susanne; Grönbladh, Alfhild; Pereira, Maria J. et al.

Ingår i Physiology and Behavior, 2025

• DOI för Cafeteria diet and caloric restriction affect metabolic but not behavioral characteristics in male Wistar rats
• Ladda ner fulltext (pdf) av Cafeteria diet and caloric restriction affect metabolic but not behavioral characteristics in male Wistar rats

Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes

Ahmed, Fozia; Hetty, Susanne; Laterveer, Rutger; Surucu, Ece Busra et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, 2025

• DOI för Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes
• Ladda ner fulltext (pdf) av Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes

Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide data

Patsoukaki, Vagia; Lind, Lars; Lampa, Erik; Radhi, Sadiq et al.

Ingår i The Lancet Diabetes and Endocrinology, s. 848-862, 2025

• DOI för Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide data

Hormonal adaptations to weight loss: Responses to an oral glucose load 4 weeks after obesity surgery and low-energy diet

Fanni, Giovanni; Hukema, Fleur W.; Hetty, Susanne; Mathioudaki, Argyri et al.

Ingår i Diabetes, obesity and metabolism, s. 4836-4846, 2025

• DOI för Hormonal adaptations to weight loss: Responses to an oral glucose load 4 weeks after obesity surgery and low-energy diet
• Ladda ner fulltext (pdf) av Hormonal adaptations to weight loss: Responses to an oral glucose load 4 weeks after obesity surgery and low-energy diet

Impact of genetic variants linked to liver fat and liver volume on MRI-mapped body composition

Ahmad, Shafqat; Carrasquilla, German D.; Langner, Taro; Menzel, Uwe et al.

Ingår i JHEP Reports, 2025

• DOI för Impact of genetic variants linked to liver fat and liver volume on MRI-mapped body composition
• Ladda ner fulltext (pdf) av Impact of genetic variants linked to liver fat and liver volume on MRI-mapped body composition

Hormonal adaptations to weight loss: Responses to an oral glucose load 4 weeks after obesity surgery and low-energy diet

Fanni, Giovanni; Hukema, Fleur W.; Hetty, Susanne; Mathioudaki, Argyri et al.

Ingår i Diabetes, obesity and metabolism, s. 4836-4846, 2025

• DOI för Hormonal adaptations to weight loss: Responses to an oral glucose load 4 weeks after obesity surgery and low-energy diet
• Ladda ner fulltext (pdf) av Hormonal adaptations to weight loss: Responses to an oral glucose load 4 weeks after obesity surgery and low-energy diet

Depot-specific metabolic and inflammatory profiles in perirenal and renal sinus adipose tissue

Pereira, Maria J.; Mathioudaki, Argyri; Hetty, Susanne; Sedigh, Amir et al.

Ingår i Molecular Medicine, 2025

• DOI för Depot-specific metabolic and inflammatory profiles in perirenal and renal sinus adipose tissue
• Ladda ner fulltext (pdf) av Depot-specific metabolic and inflammatory profiles in perirenal and renal sinus adipose tissue

Abundance of dopamine and its receptors in the brain and adipose tissue following diet-induced obesity or caloric restriction

Hukema, Fleur W.; Hetty, Susanne; Kagios, Christakis; Zelleroth, Sofia et al.

Ingår i Translational Research, s. 41-54, 2025

• DOI för Abundance of dopamine and its receptors in the brain and adipose tissue following diet-induced obesity or caloric restriction
• Ladda ner fulltext (pdf) av Abundance of dopamine and its receptors in the brain and adipose tissue following diet-induced obesity or caloric restriction

Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

Gigante, Bruna; Chen, Qiaosen; Björkbacka, Harry; Björnson, Elias et al.

Ingår i International Journal of Cardiology, 2025

• DOI för Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis
• Ladda ner fulltext (pdf) av Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated ¹⁸F-FDG-PET/MRI

Eriksson, Jan; Pereira, Maria J.; Kagios, Christakis; Kvernby, Sofia et al.

Ingår i Diabetologia, s. 1399-1412, 2024

• DOI för Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated ¹⁸F-FDG-PET/MRI
• Ladda ner fulltext (pdf) av Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated ¹⁸F-FDG-PET/MRI

Regional brain glucose uptake following gastric bypass surgery during normo- and hypoglycemic clamp: a pilot FDG-PET study

Fanni, Giovanni; Kvernby, Sofia; Radhi, Sadiq; Mathioudaki, Argyri et al.

Ingår i Endocrine, 2024

• DOI för Regional brain glucose uptake following gastric bypass surgery during normo- and hypoglycemic clamp: a pilot FDG-PET study
• Ladda ner fulltext (pdf) av Regional brain glucose uptake following gastric bypass surgery during normo- and hypoglycemic clamp: a pilot FDG-PET study

Metabolomic Profiling of Adipose Tissue in Type 2 Diabetes: Associations with Obesity and Insulin Resistance

Mathioudaki, Argyri; Fanni, Giovanni; Eriksson, Jan W.; Pereira, Maria J.

Ingår i Metabolites, 2024

• DOI för Metabolomic Profiling of Adipose Tissue in Type 2 Diabetes: Associations with Obesity and Insulin Resistance
• Ladda ner fulltext (pdf) av Metabolomic Profiling of Adipose Tissue in Type 2 Diabetes: Associations with Obesity and Insulin Resistance

A pilot study of a joint outdoor exercise program for dog owners and dogs

Smedberg, K.; Lundbeck, E.; Roman, Erika; Eriksson, Jan W. et al.

Ingår i Scientific Reports, 2024

• DOI för A pilot study of a joint outdoor exercise program for dog owners and dogs
• Ladda ner fulltext (pdf) av A pilot study of a joint outdoor exercise program for dog owners and dogs

Similar early metabolic changes induced by dietary weight loss or bariatric surgery. Reply to Taylor R [letter].

Eriksson, Jan W; Pereira, Maria J.; Fanni, Giovanni; Risérus, Ulf et al.

Ingår i Diabetologia, s. 2605-2607, 2024

• DOI för Similar early metabolic changes induced by dietary weight loss or bariatric surgery. Reply to Taylor R [letter].

Autonomic nervous system responses to hypo- and hyperglycemia in type 2 diabetes and prediabetes

Lundqvist, Martin H.; Pereira, Maria J.; Wiklund, Urban; Hetty, Susanne et al.

Ingår i European Journal of Endocrinology, s. 499-508, 2024

• DOI för Autonomic nervous system responses to hypo- and hyperglycemia in type 2 diabetes and prediabetes
• Ladda ner fulltext (pdf) av Autonomic nervous system responses to hypo- and hyperglycemia in type 2 diabetes and prediabetes

Renal sinus adipose tissue: exploratory study of metabolic features and transcriptome compared with omental and subcutaneous adipose tissue

Pereira, Maria J.; Mathioudaki, Argyri; Otero, Alicia G.; Duvvuri, Padma Priya et al.

Ingår i Obesity, s. 1870-1884, 2024

• DOI för Renal sinus adipose tissue: exploratory study of metabolic features and transcriptome compared with omental and subcutaneous adipose tissue
• Ladda ner fulltext (pdf) av Renal sinus adipose tissue: exploratory study of metabolic features and transcriptome compared with omental and subcutaneous adipose tissue

Regulation of the Cortisol Axis, Glucagon, and Growth Hormone by Glucose Is Altered in Prediabetes and Type 2 Diabetes

Lundqvist, Martin H.; Pereira, Maria J.; Almby, Kristina E.; Hetty, Susanne et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, 2024

• DOI för Regulation of the Cortisol Axis, Glucagon, and Growth Hormone by Glucose Is Altered in Prediabetes and Type 2 Diabetes
• Ladda ner fulltext (pdf) av Regulation of the Cortisol Axis, Glucagon, and Growth Hormone by Glucose Is Altered in Prediabetes and Type 2 Diabetes

Subcutaneous adipose tissue dopamine D2 receptor expression is increased in prediabetes and T2D

Vranic, Milica; Ahmed, Fozia; Kristófi, Robin; Hetty, Susanne et al.

Ingår i Endocrine, 2024

• DOI för Subcutaneous adipose tissue dopamine D2 receptor expression is increased in prediabetes and T2D
• Ladda ner fulltext (pdf) av Subcutaneous adipose tissue dopamine D2 receptor expression is increased in prediabetes and T2D

CD248 promotes insulin resistance by binding to the insulin receptor and dampening its insulin-induced autophosphorylation

Benedet, Patricia O.; Safikhan, Nooshin S.; Pereira, Maria J.; Lum, Bryan M. et al.

Ingår i EBioMedicine, 2024

• DOI för CD248 promotes insulin resistance by binding to the insulin receptor and dampening its insulin-induced autophosphorylation
• Ladda ner fulltext (pdf) av CD248 promotes insulin resistance by binding to the insulin receptor and dampening its insulin-induced autophosphorylation

History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study

Ritsinger, Viveca; Bodegard, Johan; Kristófi, Robin; Thuresson, Marcus et al.

Ingår i BMJ Open, 2023

• DOI för History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study
• Ladda ner fulltext (pdf) av History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study

Complementary elements of support after gastric-bypass surgery perceived by adults with previous type 2 diabetes: A qualitative study 2 years after bariatric surgery

Randell, Eva; Katsogiannos, Petros; Leksell, Janeth; Eriksson, Jan W. et al.

Ingår i Clinical Obesity, 2023

• DOI för Complementary elements of support after gastric-bypass surgery perceived by adults with previous type 2 diabetes: A qualitative study 2 years after bariatric surgery
• Ladda ner fulltext (pdf) av Complementary elements of support after gastric-bypass surgery perceived by adults with previous type 2 diabetes: A qualitative study 2 years after bariatric surgery

Effects of gastric bypass surgery on brain connectivity responses to hypoglycemia

Fanni, Giovanni; Kagios, Christakis; Roman, Erika; Sundbom, Magnus et al.

Ingår i Endocrine, s. 304-312, 2023

• DOI för Effects of gastric bypass surgery on brain connectivity responses to hypoglycemia
• Ladda ner fulltext (pdf) av Effects of gastric bypass surgery on brain connectivity responses to hypoglycemia

Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes

Lundqvist, Martin H.; Patsoukaki, Vagia; Jansson, Stefan P.O.; Norman, Henrietta et al.

Ingår i Diabetes & Vascular Disease Research, 2023

• DOI för Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes
• Ladda ner fulltext (pdf) av Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes

CABLES1 expression is reduced in human subcutaneous adipose tissue in obesity and type 2 diabetes but may not directly impact adipocyte glucose and lipid metabolism

Hetty, Susanne; Vranic, Milica; Kamble, Prasad G.; Lundqvist, Martin H. et al.

Ingår i Adipocyte, 2023

• DOI för CABLES1 expression is reduced in human subcutaneous adipose tissue in obesity and type 2 diabetes but may not directly impact adipocyte glucose and lipid metabolism
• Ladda ner fulltext (pdf) av CABLES1 expression is reduced in human subcutaneous adipose tissue in obesity and type 2 diabetes but may not directly impact adipocyte glucose and lipid metabolism

Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study

Fanni, Giovanni; Eriksson, Jan; Pereira, Maria J.

Ingår i Metabolites, 2023

• DOI för Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study
• Ladda ner fulltext (pdf) av Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study

Increased OCT3 Expression in Adipose Tissue With Aging: Implications for Catecholamine and Lipid Turnover and Insulin Resistance in Women

Ahmed, Fozia; Vranic, Milica; Hetty, Susanne; Mathioudaki, Argyri et al.

Ingår i Endocrinology, 2023

• DOI för Increased OCT3 Expression in Adipose Tissue With Aging: Implications for Catecholamine and Lipid Turnover and Insulin Resistance in Women
• Ladda ner fulltext (pdf) av Increased OCT3 Expression in Adipose Tissue With Aging: Implications for Catecholamine and Lipid Turnover and Insulin Resistance in Women

Virtual clinic for young people with type 1 diabetes: a randomised wait-list controlled study

Leksell, Janeth; Toft, Eva; Rosman, Jessica; Eriksson, Jan W. et al.

Ingår i BMC Endocrine Disorders, 2023

• DOI för Virtual clinic for young people with type 1 diabetes: a randomised wait-list controlled study
• Ladda ner fulltext (pdf) av Virtual clinic for young people with type 1 diabetes: a randomised wait-list controlled study

Glucose-dependent inflammatory responses in obese compared to lean individuals

Lundqvist, Martin H.; Pereira, Maria J.; Eriksson, Jan

Ingår i Endocrine, s. 464-476, 2023

• DOI för Glucose-dependent inflammatory responses in obese compared to lean individuals
• Ladda ner fulltext (pdf) av Glucose-dependent inflammatory responses in obese compared to lean individuals

Altered glucose-dependent secretion of glucagon and ACTH is associated with insulin resistance, assessed by population analysis

Eriksson, Jan; Emad, Reem A.; Lundqvist, Martin H.; Abrahamsson, Niclas et al.

Ingår i Endocrine Connections, 2023

• DOI för Altered glucose-dependent secretion of glucagon and ACTH is associated with insulin resistance, assessed by population analysis
• Ladda ner fulltext (pdf) av Altered glucose-dependent secretion of glucagon and ACTH is associated with insulin resistance, assessed by population analysis

Positional and compositional analysis of saturated, monounsaturated, and polyunsaturated fatty acids in human adipose tissue triglyceride by ¹³ C nuclear magnetic resonance

Torres, Alejandra N; Tavares, Ludgero; Pereira, Maria J.; Eriksson, Jan et al.

Ingår i NMR in Biomedicine, 2023

• DOI för Positional and compositional analysis of saturated, monounsaturated, and polyunsaturated fatty acids in human adipose tissue triglyceride by ¹³ C nuclear magnetic resonance

Effects of the second-generation antipsychotic drugs aripiprazole and olanzapine on human adipocyte differentiation

Vranic, Milica; Ahmed, Fozia; Hetty, Susanne; Sarsenbayeva, Assel et al.

Ingår i Molecular and Cellular Endocrinology, 2023

• DOI för Effects of the second-generation antipsychotic drugs aripiprazole and olanzapine on human adipocyte differentiation
• Ladda ner fulltext (pdf) av Effects of the second-generation antipsychotic drugs aripiprazole and olanzapine on human adipocyte differentiation

Interleukin-33 inhibits glucose uptake in human adipocytes and its expression in adipose tissue is elevated in insulin resistance and type 2 diabetes

Pereira, Maria J.; Azim, Ayesha; Hetty, Susanne; Jui Nandi, Bipasha et al.

Ingår i Cytokine, 2023

• DOI för Interleukin-33 inhibits glucose uptake in human adipocytes and its expression in adipose tissue is elevated in insulin resistance and type 2 diabetes
• Ladda ner fulltext (pdf) av Interleukin-33 inhibits glucose uptake in human adipocytes and its expression in adipose tissue is elevated in insulin resistance and type 2 diabetes

Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women

Ahmed, Fozia; Kamble, Prasad G.; Hetty, Susanne; Fanni, Giovanni et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, 2022

• DOI för Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women
• Ladda ner fulltext (pdf) av Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women

Response of multiple hormones to glucose and arginine challenge in T2DM after gastric bypass

Fanni, Giovanni; Katsogiannos, Petros; Jui Nandi, Bipasha; Sundbom, Magnus et al.

Ingår i Endocrine Connections, 2022

• DOI för Response of multiple hormones to glucose and arginine challenge in T2DM after gastric bypass
• Ladda ner fulltext (pdf) av Response of multiple hormones to glucose and arginine challenge in T2DM after gastric bypass

Special Issue on Metabolism and Metabolite Markers in Type 2 Diabetes

Eriksson, Jan

Ingår i Metabolites, 2022

• DOI för Special Issue on Metabolism and Metabolite Markers in Type 2 Diabetes
• Ladda ner fulltext (pdf) av Special Issue on Metabolism and Metabolite Markers in Type 2 Diabetes

ESR2 expression in subcutaneous adipose tissue is related to body fat distribution in women, and knockdown impairs preadipocyte differentiation

Ahmed, Fozia; Hetty, Susanne; Vranic, Milica; Fanni, Giovanni et al.

Ingår i Adipocyte, s. 434-447, 2022

• DOI för ESR2 expression in subcutaneous adipose tissue is related to body fat distribution in women, and knockdown impairs preadipocyte differentiation
• Ladda ner fulltext (pdf) av ESR2 expression in subcutaneous adipose tissue is related to body fat distribution in women, and knockdown impairs preadipocyte differentiation

Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data

Kristófi, Robin; Bodegard, Johan; Ritsinger, Viveca; Thuresson, Marcus et al.

Ingår i Cardiovascular Diabetology, 2022

• DOI för Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data
• Ladda ner fulltext (pdf) av Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data

Individual goal-based plan based on nursing theory for adults with type 2 diabetes and self-care deficits: a study protocol of a randomised controlled trial

Rosman, Jessica; Eriksson, Jan; Martinell, Mats; Lindholm Olinder, Anna et al.

Ingår i BMJ Open, 2022

• DOI för Individual goal-based plan based on nursing theory for adults with type 2 diabetes and self-care deficits: a study protocol of a randomised controlled trial
• Ladda ner fulltext (pdf) av Individual goal-based plan based on nursing theory for adults with type 2 diabetes and self-care deficits: a study protocol of a randomised controlled trial

CDKN2C expression in adipose tissue is reduced in type II diabetes and central obesity: impact on adipocyte differentiation and lipid storage?

Pereira, Maria J.; Vranic, Milica; Kamble, Prasad G.; Jernow, Henning et al.

Ingår i Translational Research, s. 105-121, 2022

• DOI för CDKN2C expression in adipose tissue is reduced in type II diabetes and central obesity: impact on adipocyte differentiation and lipid storage?
• Ladda ner fulltext (pdf) av CDKN2C expression in adipose tissue is reduced in type II diabetes and central obesity: impact on adipocyte differentiation and lipid storage?

Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight

Ferreira, Vitor; Folgueira, Cintia; Guillen, Maria; Zubiaur, Pablo et al.

Ingår i Metabolism, 2022

• DOI för Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight
• Ladda ner fulltext (pdf) av Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight

Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues

Diamanti, Klev; Cavalli, Marco; Pereira, Maria J.; Pan, Gang et al.

Ingår i Cell Reports Medicine, 2022

• DOI för Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues
• Ladda ner fulltext (pdf) av Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues

Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries

Norhammar, Anna; Bodegard, Johan; Eriksson, Jan W.; Haller, Hermann et al.

Ingår i Diabetes, obesity and metabolism, s. 1277-1287, 2022

• DOI för Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries
• Ladda ner fulltext (pdf) av Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries

Excess glucocorticoid exposure contributes to adipose tissue fibrosis which involves macrophage interaction with adipose precursor cells

Sarsenbayeva, Assel; Pereira, Maria J.; Jui Nandi, Bipasha; Ahmed, Fozia et al.

Ingår i Biochemical Pharmacology, 2022

• DOI för Excess glucocorticoid exposure contributes to adipose tissue fibrosis which involves macrophage interaction with adipose precursor cells
• Ladda ner fulltext (pdf) av Excess glucocorticoid exposure contributes to adipose tissue fibrosis which involves macrophage interaction with adipose precursor cells

Macrophage-derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes

Dipta, Priya; Sarsenbayeva, Assel; Shmuel, Miriam; Forno, Francesca et al.

Ingår i Comprehensive Psychoneuroendocrinology, 2021

• DOI för Macrophage-derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes
• Ladda ner fulltext (pdf) av Macrophage-derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes

A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol

Sundström, Johan; Kristofi, Robin; Östlund, Ollie; Bennet, Louise et al.

Ingår i Journal of diabetes and its complications, 2021

• DOI för A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
• Ladda ner fulltext (pdf) av A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol

Impaired HMG-CoA reductase activity caused by genetic variants or statin exposure: impact on human adipose tissue, β-cells and metabolome

Sarsenbayeva, Assel; Jui Nandi, Bipasha; Fanni, Giovanni; Barbosa, Pedro et al.

Ingår i Metabolites, 2021

• DOI för Impaired HMG-CoA reductase activity caused by genetic variants or statin exposure: impact on human adipose tissue, β-cells and metabolome
• Ladda ner fulltext (pdf) av Impaired HMG-CoA reductase activity caused by genetic variants or statin exposure: impact on human adipose tissue, β-cells and metabolome

Tissue-specific glucose partitioning and fat content in prediabetes and type 2 diabetes: whole-body PET/MRI during hyperinsulinemia

Eriksson, Jan W; Visvanathar, Robin; Kullberg, Joel; Strand, Robin et al.

Ingår i European Journal of Endocrinology, s. 879-889, 2021

• DOI för Tissue-specific glucose partitioning and fat content in prediabetes and type 2 diabetes: whole-body PET/MRI during hyperinsulinemia

Time Course of Metabolic, Neuroendocrine, and Adipose Effects During 2 Years of Follow-up After Gastric Bypass in Patients With Type 2 Diabetes

Almby, Kristina E.; Katsogiannos, Petros; Pereira, Maria J.; Karlsson, Anders et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, 2021

• DOI för Time Course of Metabolic, Neuroendocrine, and Adipose Effects During 2 Years of Follow-up After Gastric Bypass in Patients With Type 2 Diabetes
• Ladda ner fulltext (pdf) av Time Course of Metabolic, Neuroendocrine, and Adipose Effects During 2 Years of Follow-up After Gastric Bypass in Patients With Type 2 Diabetes

The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat

Lind, Lars; Salihovic, Samira; Risérus, Ulf; Kullberg, Joel et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, 2021

• DOI för The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat
• Ladda ner fulltext (pdf) av The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat

Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes.

Lundqvist, Martin H.; Almby, Kristina E.; Wiklund, Urban; Abrahamsson, Niclas et al.

Ingår i Diabetologia, s. 641-655, 2021

• DOI för Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes.

Quality of life of type 2 diabetes mellitus patients in Ramallah and al-Bireh Governorate-Palestine: a part of the Palestinian diabetes complications and control study (PDCCS)

Tietjen, Anna Katharina; Ghandour, Rula; Mikki, Nahed; Jerden, Lars et al.

Ingår i Quality of Life Research, s. 1407-1416, 2021

• DOI för Quality of life of type 2 diabetes mellitus patients in Ramallah and al-Bireh Governorate-Palestine: a part of the Palestinian diabetes complications and control study (PDCCS)
• Ladda ner fulltext (pdf) av Quality of life of type 2 diabetes mellitus patients in Ramallah and al-Bireh Governorate-Palestine: a part of the Palestinian diabetes complications and control study (PDCCS)

Lower cardiorenal risk withsodium-glucosecotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study

Birkeland, Kare I.; Bodegard, Johan; Banerjee, Amitava; Kim, Dae Jung et al.

Ingår i Diabetes, obesity and metabolism, s. 75-85, 2021

• DOI för Lower cardiorenal risk withsodium-glucosecotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
• Ladda ner fulltext (pdf) av Lower cardiorenal risk withsodium-glucosecotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study

Human macrophages stimulate expression of inflammatory mediators in adipocytes; effects of second-generation antipsychotics and glucocorticoids on cellular cross-talk

Sarsenbayeva, Assel; Dipta, Priya; Lundqvist, Martin H.; Almby, Kristina E. et al.

Ingår i Psychoneuroendocrinology, 2021

• DOI för Human macrophages stimulate expression of inflammatory mediators in adipocytes; effects of second-generation antipsychotics and glucocorticoids on cellular cross-talk
• Ladda ner fulltext (pdf) av Human macrophages stimulate expression of inflammatory mediators in adipocytes; effects of second-generation antipsychotics and glucocorticoids on cellular cross-talk

Effects of Gastric Bypass Surgery on the Brain: Simultaneous Assessment of Glucose Uptake, Blood Flow, Neural Activity, and Cognitive Function During Normo- and Hypoglycemia

Almby, Kristina E.; Lundqvist, Martin H.; Abrahamsson, Niclas; Kvernby, Sofia et al.

Ingår i Diabetes, s. 1265-1277, 2021

• DOI för Effects of Gastric Bypass Surgery on the Brain: Simultaneous Assessment of Glucose Uptake, Blood Flow, Neural Activity, and Cognitive Function During Normo- and Hypoglycemia

Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study

Kristofi, Robin; Bodegard, Johan; Norhammar, Anna; Thuresson, Marcus et al.

Ingår i Diabetes Care, s. 1211-1218, 2021

• DOI för Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study

Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without Type 2 Diabetes

Katsogiannos, Petros; Kamble, Prasad G.; Pereira, Maria J.; Sundbom, Magnus et al.

Ingår i Obesity, s. 535-542, 2021

• DOI för Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without Type 2 Diabetes
• Ladda ner fulltext (pdf) av Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without Type 2 Diabetes

Integration of whole-body [¹⁸F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes

Diamanti, Klev; Visvanathar, Robin; Pereira, Maria J.; Cavalli, Marco et al.

Ingår i Scientific Reports, 2020

• DOI för Integration of whole-body [¹⁸F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes
• Ladda ner fulltext (pdf) av Integration of whole-body [¹⁸F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes

Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population

Lind, Lars; Johansson, Lars; Ahlström, Håkan; Eriksson, Jan W. et al.

Ingår i World Journal of Hepatology, s. 149-159, 2020

• DOI för Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population
• Ladda ner fulltext (pdf) av Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population

Quality of life after gastric bypass surgery in patients with type 2 diabetes: patients' experiences during 2 years of follow-up

Katsogiannos, Petros; Randell, Eva; Sundbom, Magnus; Rosenblad, Andreas et al.

Ingår i Diabetology & Metabolic Syndrome, 2020

• DOI för Quality of life after gastric bypass surgery in patients with type 2 diabetes: patients' experiences during 2 years of follow-up
• Ladda ner fulltext (pdf) av Quality of life after gastric bypass surgery in patients with type 2 diabetes: patients' experiences during 2 years of follow-up

Sleep apnea in men is associated with altered lipid metabolism, glucose tolerance, insulin sensitivity, and body fat percentage.

Kamble, Prasad G.; Theorell-Haglöw, Jenny; Wiklund, Urban; Franklin, Karl A et al.

Ingår i Endocrine, s. 48-57, 2020

• DOI för Sleep apnea in men is associated with altered lipid metabolism, glucose tolerance, insulin sensitivity, and body fat percentage.

Rapid changes in neuroendocrine regulation may contribute to reversal of type 2 diabetes after gastric bypass surgery

Katsogiannos, Petros; Kamble, Prasad G.; Wiklund, Urban; Sundbom, Magnus et al.

Ingår i Endocrine, s. 344-353, 2020

• DOI för Rapid changes in neuroendocrine regulation may contribute to reversal of type 2 diabetes after gastric bypass surgery
• Ladda ner fulltext (pdf) av Rapid changes in neuroendocrine regulation may contribute to reversal of type 2 diabetes after gastric bypass surgery

Proof-of-concept for CRISPR/Cas9 gene editing in human preadipocytes: Deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism

Kamble, Prasad G.; Hetty, Susanne; Vranic, Milica; Almby, Kristina et al.

Ingår i Scientific Reports, 2020

• DOI för Proof-of-concept for CRISPR/Cas9 gene editing in human preadipocytes: Deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism
• Ladda ner fulltext (pdf) av Proof-of-concept for CRISPR/Cas9 gene editing in human preadipocytes: Deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism

Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study

Birkeland, Kåre I.; Bodegard, Johan; Eriksson, Jan W.; Norhammar, Anna et al.

Ingår i Diabetes, obesity and metabolism, s. 1607-1618, 2020

• DOI för Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
• Ladda ner fulltext (pdf) av Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study

Validation of automated whole-body analysis of metabolic and morphological parameters from an integrated FDG-PET/MRI acquisition

Guglielmo, Priscilla; Ekström, Simon; Strand, Robin; Visvanathar, Robin et al.

Ingår i Scientific Reports, 2020

• DOI för Validation of automated whole-body analysis of metabolic and morphological parameters from an integrated FDG-PET/MRI acquisition
• Ladda ner fulltext (pdf) av Validation of automated whole-body analysis of metabolic and morphological parameters from an integrated FDG-PET/MRI acquisition

Long‐term follow‐up of antivascular endothelial growth factor treatment for diabetic macular oedema: a four‐year real‐world study

Granstam, Elisabet; Rosenblad Karlsson, Andreas; Modher Raghib, Aseel; Granström, Therese et al.

Ingår i Acta Ophthalmologica, s. 360-367, 2020

• DOI för Long‐term follow‐up of antivascular endothelial growth factor treatment for diabetic macular oedema: a four‐year real‐world study

Type B insulin resistance syndrome in a patient with type 1 diabetes

Sjoholm, Ake; Pereira, Maria João; Nilsson, Thomas; Linde, Torbjörn et al.

Ingår i Endocrinology, diabetes & metabolism case reports, 2020

• DOI för Type B insulin resistance syndrome in a patient with type 1 diabetes
• Ladda ner fulltext (pdf) av Type B insulin resistance syndrome in a patient with type 1 diabetes

A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes

Mulder, Skander; Hammarstedt, Ann; Nagaraj, Sunil B.; Nair, Viji et al.

Ingår i Diabetes, obesity and metabolism, s. 1157-1166, 2020

• DOI för A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes
• Ladda ner fulltext (pdf) av A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes

Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes

Pereira, Maria J; Thombare, Ketan; Sarsenbayeva, Assel; Kamble, Prasad G. et al.

Ingår i Molecular and Cellular Endocrinology, 2020

• DOI för Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes

Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D

Katsogiannos, Petros; Kamble, Prasad G.; Boersma, Greta J.; Karlsson, F. Anders et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, s. 2601-2613, 2019

• DOI för Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D

Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner

Edén, Desireé; Panagiotou, Grigorios; Mokhtari, Dariush; Eriksson, Jan et al.

Ingår i Upsala Journal of Medical Sciences, s. 158-167, 2019

• DOI för Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner
• Ladda ner fulltext (pdf) av Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner

Effects of GLP-1 on counter-regulatory responses during hypoglycemia after GBP surgery

Almby, Kristina E.; Abrahamsson, Niclas; Lundqvist, Martin H.; Hammar, Ulf et al.

Ingår i European Journal of Endocrinology, s. 161-171, 2019

• DOI för Effects of GLP-1 on counter-regulatory responses during hypoglycemia after GBP surgery

Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes

Diamanti, Klev; Cavalli, Marco; Pan, Gang; Pereira, Maria J et al.

Ingår i Scientific Reports, 2019

• DOI för Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes
• Ladda ner fulltext (pdf) av Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes

Effects of second-generation antipsychotics on human subcutaneous adipose tissue metabolism

Sarsenbayeva, Assel; Marques-Santos, Cátia M.; Thombare, Ketan; Di Nunzio, Giada et al.

Ingår i Psychoneuroendocrinology, 2019

• DOI för Effects of second-generation antipsychotics on human subcutaneous adipose tissue metabolism
• Ladda ner fulltext (pdf) av Effects of second-generation antipsychotics on human subcutaneous adipose tissue metabolism

Dapagliflozin vs non-SGLT-2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE-TIMI 58 trial: A nationwide observational study

Norhammar, Anna; Bodegard, Johan; Nystrom, Thomas; Thuresson, Marcus et al.

Ingår i Diabetes, obesity and metabolism, s. 2651-2659, 2019

• DOI för Dapagliflozin vs non-SGLT-2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE-TIMI 58 trial: A nationwide observational study
• Ladda ner fulltext (pdf) av Dapagliflozin vs non-SGLT-2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE-TIMI 58 trial: A nationwide observational study

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Mosenzon, Ofri; Blicher, Thalia Marie; Rosenlund, Signe; Eriksson, Jan et al.

Ingår i The Lancet Diabetes and Endocrinology, s. 515-527, 2019

• DOI för Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Estrogen interacts with glucocorticoids in the regulation of lipocalin 2 expression in human adipose tissue. Reciprocal roles of estrogen receptor alpha and beta in insulin resistance?

Kamble, Prasad G.; Pereira, Maria J; Almby, Kristina E.; Eriksson, Jan

Ingår i Molecular and Cellular Endocrinology, s. 28-36, 2019

• DOI för Estrogen interacts with glucocorticoids in the regulation of lipocalin 2 expression in human adipose tissue. Reciprocal roles of estrogen receptor alpha and beta in insulin resistance?

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study

Norhammar, Anna; Bodegård, Johan; Nyström, Thomas; Thuresson, Marcus et al.

Ingår i Diabetes, obesity and metabolism, s. 1136-1145, 2019

• DOI för Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study
• Ladda ner fulltext (pdf) av Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study

Plasma metabolomic patterns in patients with exhaustion disorder

Hadrévi, Jenny; Jonsdottir, Ingibjorg H.; Jansson, Per-Anders; Eriksson, Jan W. et al.

Ingår i Stress, s. 17-26, 2019

• DOI för Plasma metabolomic patterns in patients with exhaustion disorder
• Ladda ner fulltext (pdf) av Plasma metabolomic patterns in patients with exhaustion disorder

Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes.

Lundkvist, Per; Pereira, Maria J.; Kamble, Prasad G.; Katsogiannos, Petros et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, s. 193-201, 2019

• DOI för Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes.

Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity

Pereira, Maria J; Eriksson, Jan

Ingår i Drugs, s. 219-230, 2019

• DOI för Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity
• Ladda ner fulltext (pdf) av Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity

Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study.

Persson, Frederik; Bodegard, Johan; Lahtela, Jorma T; Nyström, Thomas et al.

Ingår i Endocrinology, Diabetes & Metabolism, 2018

• DOI för Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study.

Calcineurin is an important factor involved in glucose uptake in human adipocytes

Fonseca, Ana Catarina R. G.; Carvalho, Eugenia; Eriksson, Jan; Pereira, Maria J

Ingår i Molecular and Cellular Biochemistry, s. 157-168, 2018

• DOI för Calcineurin is an important factor involved in glucose uptake in human adipocytes
• Ladda ner fulltext (pdf) av Calcineurin is an important factor involved in glucose uptake in human adipocytes

Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study

Oscarsson, Jan; Onnerhag, Kristina; Risérus, Ulf; Sunden, Mattias et al.

Ingår i Journal of Clinical Lipidology, s. 1390-1403, 2018

• DOI för Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study
• Ladda ner fulltext (pdf) av Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study

Adipocytes are coagulant active in a TF/FVIIa dependent manner but lipolysis is unaffected by TF/FVIIa

Edén, Desireé; Mokhtari, Dariush; Eriksson, Jan W; Åberg, Mikael et al.

Ingår i Cardiovascular Research, 2018

FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes

Sidibeh, Cherno O; Pereira, Maria J; Abalo, Xesus; Boersma, Gretha J. et al.

Ingår i Endocrine, s. 116-128, 2018

• DOI för FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes
• Ladda ner fulltext (pdf) av FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes

Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction

Hansson, Sara F.; Zhou, Alex-Xianghua; Vachet, Pauline; Eriksson, Jan W et al.

Ingår i PLOS ONE, 2018

• DOI för Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction
• Ladda ner fulltext (pdf) av Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction

Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014

Nathanson, David; Sabale, Ugne; Eriksson, Jan; Nyström, Thomas et al.

Ingår i PHARMACOECONOMICS-OPEN, s. 393-402, 2018

• DOI för Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014
• Ladda ner fulltext (pdf) av Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study

Eriksson, Jan W.; Lundkvist, Per; Jansson, Per-Anders; Johansson, Lars et al.

Ingår i Diabetologia, s. 1923-1934, 2018

• DOI för Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
• Ladda ner fulltext (pdf) av Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study

Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover.

Kamble, Prasad G.; Pereira, Maria J; Gustafsson, Stefan; Lundkvist, Per et al.

Ingår i Adipocyte, s. 285-296, 2018

• DOI för Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover.
• Ladda ner fulltext (pdf) av Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover.

Complications of type 2 diabetes mellitus in Ramallah and al-Bireh: The Palestinian Diabetes Complications and Control Study (PDCCS)

Ghandour, Rula; Mikki, Nahed; Abu Rmeileh, Niveen M. E.; Jerden, Lars et al.

Ingår i Primary Care Diabetes, s. 547-557, 2018

• DOI för Complications of type 2 diabetes mellitus in Ramallah and al-Bireh: The Palestinian Diabetes Complications and Control Study (PDCCS)

FKBP51 ablation using CRISPR/Cas-9 impairs adipocyte differentiation

Castillejo-Lopez, Casimiro; Abalo, Xesus M.; Sidibeh, Cherno O; Pereira, Maria J et al.

Ingår i Diabetologia, 2018

SGLT2i vs bolus insulin as add-on to stable basal insulin treatment in type 2 diabetes and risk of cardiovascular disease and mortality: a nationwide observational study

Eriksson, Jan; Bodegard, J.; Norhammar, A.; Thuresson, M. et al.

Ingår i Diabetologia, 2018

Direct effects of glucagon on human adipose tissue metabolism

Pereira, Maria J; Boersma, Greta J.; Kamble, Prasad G.; Lundkvist, Per et al.

Ingår i Diabetologia, 2018

Estrogen and glucocorticoid effects on lipocalin 2 expression in human adipose tissue: A role of ER beta pathway in insulin resistance?

Kamble, Prasad G.; Pereira, Maria J; Boersma, Greta J.; Almby, Kristina E. et al.

Ingår i Diabetologia, 2018

Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study

Boersma, Greta J.; Johansson, Emil; Pereira, Maria J; Heurling, Kerstin et al.

Ingår i Hormone and Metabolic Research, s. 627-639, 2018

• DOI för Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study

A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss

Pereira, Maria J; Lundkvist, Per; Kamble, Prasad G.; Lau, Joey et al.

Ingår i Diabetes Therapy, s. 1511-1532, 2018

• DOI för A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
• Ladda ner fulltext (pdf) av A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss

Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10

Nyström, Thomas; Bodegård, Johan; Nathanson, David; Thuresson, Marcus et al.

Ingår i Diabetes Care, 2018

• DOI för Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10

Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study

Persson, Frederik; Nystrom, Thomas; Jorgensen, Marit E.; Carstensen, Bendix et al.

Ingår i Diabetes, obesity and metabolism, s. 344-351, 2018

• DOI för Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study

Whole-Body Imaging of Tissue-specific Insulin Sensitivity and Body Composition by Using an Integrated PET/MR System: A Feasibility Study.

Johansson, Emil; Lubberink, Mark; Heurling, Kerstin; Eriksson, Jan W. et al.

Ingår i Radiology, s. 271-278, 2018

• DOI för Whole-Body Imaging of Tissue-specific Insulin Sensitivity and Body Composition by Using an Integrated PET/MR System: A Feasibility Study.

Interrelationships Between Fatty Acid Composition in Plasma Cholesterol Esters and Phospholipids in Men and Women: A Pooled Analysis

Marklund, Matti; Pingel, Ronnie; Rosqvist, Fredrik; Lindroos, Anna Karin et al.

Ingår i Annals of Nutrition and Metabolism, s. 372-372, 2017

Fatty Acid Proportions in Plasma Cholesterol Esters and Phospholipids Are Positively Correlated in Various Swedish Populations

Marklund, Matti; Pingel, Ronnie; Rosqvist, Fredrik; Lindroos, Anna Karin et al.

Ingår i Journal of Nutrition, s. 2118-2125, 2017

• DOI för Fatty Acid Proportions in Plasma Cholesterol Esters and Phospholipids Are Positively Correlated in Various Swedish Populations

Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers

Kamble, Prasad G.; Gustafsson, Stefan; Pereira, Maria J; Lundkvist, Per et al.

Ingår i Upsala Journal of Medical Sciences, s. 234-242, 2017

• DOI för Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers
• Ladda ner fulltext (pdf) av Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers

Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance

Sidibeh, Cherno O.; Pereira, Maria J.; Börjesson, Joey Lau; Kamble, Prasad G. et al.

Ingår i Endocrine, s. 839-852, 2017

• DOI för Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance
• Ladda ner fulltext (pdf) av Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance

Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year

Lundkvist, Per; Pereira, Maria J; Katsogiannos, Petros; Sjöström, C. David et al.

Ingår i Diabetes, obesity and metabolism, s. 1276-1288, 2017

• DOI för Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year
• Ladda ner fulltext (pdf) av Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year

Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes

Lundkvist, Per; Sjöström, C. David; Amini, Sam; Pereira, Maria J. et al.

Ingår i Diabetes, obesity and metabolism, s. 49-60, 2017

• DOI för Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes
• Ladda ner fulltext (pdf) av Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes

PPARG Pro12Ala variant in relation to adipose tissue metabolism and differentiation: a small genotype-based recall study

Kamble, Prasad G.; Pereira, Maria J; Gustafsson, Stefan; Lundkvist, Per et al.

Ingår i Diabetologia, 2017

CDKN2C expression is low in type 2 diabetes and associated with reduced lipid storage capacity in subcutaneous adipose tissue and elevated free fatty acid levels

Pereira, Maria J; Skrtic, S.; Katsogiannos, Petros; Abrahamsson, Niclas et al.

Ingår i Diabetologia, 2017

Glucose homeostasis and whole-body insulin resistance improved 4 weeks after gastric bypass surgery in type 2 diabetes, whereas adipose tissue metabolism was unchanged

Katsogiannos, Petros; Boersma, Greta J.; Pereira, Maria J; Lundkvist, Per et al.

Ingår i Diabetologia, 2017

Dapagliflozin compared to DPP4i treatment is associated with lower risk of kidney disease, heart failure and all-cause death: CVD-REAL Nordic

Eriksson, Jan W; Norhammar, A.; Bodegard, J.; Thuresson, M. et al.

Ingår i Diabetologia, 2017

Calcineurin is involved in the regulation of human adipocyte glucose uptake

Fonseca, Ana R. G.; Carvalho, E.; Eriksson, Jan W; Pereira, Maria J

Ingår i Diabetologia, 2017

Glucagon levels during short-term SGLT2 inhibition are largely regulated by plasma glucose changes

Lundkvist, Per; Pereira, Maria J; Kamble, Prasad G.; Katsogiannos, Petros et al.

Ingår i Diabetologia, 2017

Glucose uptake in skeletal muscle, brain and visceral adipose tissue assessed with PET/MR strongly predicts whole body glucose uptake during hyperinsulinaemia

Boersma, Greta J.; Heurling, Kerstin; Pereira, Maria J; Johansson, Emil et al.

Ingår i Diabetologia, 2017

Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17 years after the diagnosis of diabetes: A retrospective observational nation-wide cohort study

Tyrberg, M.; Nystrom, L.; Arnqvist, H. J.; Bolinder, J. et al.

Ingår i Diabetes Research and Clinical Practice, s. 21-29, 2017

• DOI för Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17 years after the diagnosis of diabetes: A retrospective observational nation-wide cohort study

Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia

Nyström, Thomas; Bodegard, Johan; Nathanson, David; Thuresson, Marcus et al.

Ingår i Diabetes Research and Clinical Practice, s. 199-208, 2017

• DOI för Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia
• Ladda ner fulltext (pdf) av Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): A Multinational Observational Analysis

Birkeland, Kare I.; Jorgensen, Marit E.; Carstensen, Bendix; Persson, Frederik et al.

Ingår i The Lancet Diabetes and Endocrinology, s. 709-717, 2017

• DOI för Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): A Multinational Observational Analysis

Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes

Nyström, Thomas; Bodegard, Johan; Nathanson, David; Thuresson, Marcus et al.

Ingår i Diabetes, obesity and metabolism, s. 831-841, 2017

• DOI för Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes
• Ladda ner fulltext (pdf) av Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes

Effects of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, and free omega-3 carboxylic acids on liver steatosis and hepatocyte damage biomarkers in Type 2 diabetes patients with non-alcoholic fatty liver disease

Oscarsson, Jan; Lundkvist, Per; Jansson, Per-Anders E.; Johansson, Lars et al.

Ingår i Hepatology, 2016

Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity?

Svensson, Maria K.; Lindmark, Stina; Wiklund, Urban; Rask, Peter et al.

Ingår i Cardiovascular Diabetology, 2016

• DOI för Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity?
• Ladda ner fulltext (pdf) av Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity?

Patient-reported outcomes and visual acuity after 12 months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting

Granström, Therese; Forsman, Henrietta; Olinder, Anna Lindholm; Gkretsis, Dimitrios et al.

Ingår i Diabetes Research and Clinical Practice, s. 157-165, 2016

• DOI för Patient-reported outcomes and visual acuity after 12 months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting
• Ladda ner fulltext (pdf) av Patient-reported outcomes and visual acuity after 12 months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting

Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue

Kamble, Prasad G.; Pereira, Maria J.; Sidibeh, Cherno O.; Amini, Sam et al.

Ingår i Molecular and Cellular Endocrinology, s. 124-132, 2016

• DOI för Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue

Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of NEFA in type 2 diabetes. Degree of hyperglycemia and adiposity are important factors

Pereira, Maria J.; Skrtic, Stanko; Katsogiannos, Petros; Abrahamsson, Niclas et al.

Ingår i Metabolism, s. 1768-1780, 2016

• DOI för Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of NEFA in type 2 diabetes. Degree of hyperglycemia and adiposity are important factors

Gastric bypass reduces symptoms and hormonal responses to hypoglycemia

Abrahamsson, Niclas; Lau Börjesson, Joey; Sundbom, Magnus; Wiklund, Urban et al.

Ingår i Diabetes, s. 2667-2675, 2016

• DOI för Gastric bypass reduces symptoms and hormonal responses to hypoglycemia

Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up

Rautio, Aslak; Boman, Kurt; Eriksson, Jan W.; Svensson, Maria K.

Ingår i Diabetes & Vascular Disease Research, s. 183-191, 2016

• DOI för Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up

Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality

Eriksson, Jan W.; Bodegard, Johan; Nathanson, David; Thuresson, Marcus et al.

Ingår i Diabetes Research and Clinical Practice, s. 39-47, 2016

• DOI för Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality
• Ladda ner fulltext (pdf) av Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality

Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013

Norhammar, Anna; Bodegård, Johan; Nyström, Thomas; Thuresson, Marcus et al.

Ingår i Diabetologia, s. 1692-1701, 2016

• DOI för Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013

Microdialysis and proteomics of subcutaneous interstitial fluid reveals increased galectin-1 in type 2 diabetes patients

Fryk, Emanuel; Sundelin, Jeanna Perman; Strindberg, Lena; Pereira, Maria J. et al.

Ingår i Metabolism, s. 998-1006, 2016

• DOI för Microdialysis and proteomics of subcutaneous interstitial fluid reveals increased galectin-1 in type 2 diabetes patients

One year of treatment with dapagliflozin QD plus exenatide QW in obese adults without diabetes: results of an open-label extension study

Eriksson, Jan W.; Lundkvist, Per; Sjöström, C.; Katsogiannos, Petros et al.

Ingår i Diabetologia, 2016

Doubled healthcare costs of type 2 diabetes mellitus during years 2006-2014: a nationwide cost-of-illness study in Sweden

Kalkan, A.; Bodegard, J.; Ericsson, Jan W.; Nystrom, T. et al.

Ingår i Diabetologia, 2016

Role of cannabinoid receptor type 1 in glucocorticoid-induced insulin resistance (IR) and lipolysis regulation in human adipose tissue (AT)

Sidibeh, Cherno O.; Pereira, Maria J.; Börjesson, Joey Lau; Kamble, Prasad G. et al.

Ingår i Diabetologia, 2016

Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of free fatty acids in type 2 diabetes

Pereira, Maria J.; Skrtic, S.; Katsogiannos, Petros; Abrahamsson, Niclas et al.

Ingår i Diabetologia, 2016

Metabolic effects of dapagliflozin QD and exenatide QW in obese adults without diabetes: a 24-week randomised placebo-controlled phase 2 study

Lundkvist, Per; Amini, Sam; Lau Börjesson, Joey; Pereira, Maria J. et al.

Ingår i Diabetologia, 2016

Skeletal muscle and liver, but not brain, account for impaired glucose utilisation in type 2 diabetes: whole-body PET/MR during hyperinsulinaemic euglycaemic clamp

Boersma, Greta J.; Johansson, Emil; Pereira, Maria J.; Skrtic, S. et al.

Ingår i Diabetologia, 2016

A randomised wait-list controlled clinical trial of the effects of acceptance and commitment therapy in patients with type 1 diabetes: a study protocol

Lindholm Olinder, Anna; Fischier, Johan; Fries, Jenny; Alfonsson, Sven et al.

Ingår i BMC Nursing, 2015

• DOI för A randomised wait-list controlled clinical trial of the effects of acceptance and commitment therapy in patients with type 1 diabetes: a study protocol

Evaluation of reference genes for gene expression studies in human brown adipose tissue

Taube, Magdalena; Andersson-Assarsson, Johanna C; Lindberg, Kristin; Pereira, Maria J et al.

Ingår i Adipocyte, s. 280-285, 2015

• DOI för Evaluation of reference genes for gene expression studies in human brown adipose tissue

Continuous inhibition of 11 beta-hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice

Gutierrez, P. Morentin; Gyte, A.; deSchoolmeester, J.; Ceuppens, P. et al.

Ingår i British Journal of Pharmacology, s. 4806-4816, 2015

• DOI för Continuous inhibition of 11 beta-hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice

The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.

Svensson, M K; Tyrberg, M; Nyström, L; Arnqvist, H J et al.

Ingår i Diabetes/Metabolism Research Reviews, s. 138-146, 2015

• DOI för The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.

Second-line treatment with sulfonylurea compared to DPP4 inhibitors demonstrated associations with earlier treatment intensification with insulin

Bodegard, J.; Nathanson, D.; Nystrom, T.; Thuresson, M. et al.

Ingår i Diabetologia, 2015

Microdialysis and proteomics of the subcutaneous interstitial fluid reveals abundance of galectin-1 in type 2 diabetes patients

Fryk, E.; Sundelin, J. Perman; Strindberg, L.; Pereira, Maria João et al.

Ingår i Diabetologia, 2015

Second-line treatment with sulfonylurea compared to DPP4 inhibitors is associated with risk of cardiovascular disease, all-cause mortality and severe hypoglycaemia

Eriksson, Jan W.; Bodegard, J.; Norhammar, A.; Nathanson, D. et al.

Ingår i Diabetologia, 2015

Role of lipocalin 2 in human adipose tissue metabolism and glucocorticoid-induced insulin resistance

Kamble, Prasad G.; Pereira, Maria João; Sidibeh, Cherno O.; Amini, Sam et al.

Ingår i Diabetologia, 2015

Role of cannabinoid receptor type 1 in glucocorticoid-induced lipolysis, insulin resistance and central obesity in human adipose tissue

Sidibeh, Cherno O.; Pereira, Maria João; Börjesson, Joey Lau; Kamble, Prasad G. et al.

Ingår i Diabetologia, 2015

Patient characteristics, treatment and prevalence/incidence of the type 2 diabetes population in Sweden: a nationwide study from 2006 to 2013

Nathanson, D.; Norhammar, A.; Nystrom, T.; Thuresson, M. et al.

Ingår i Diabetologia, 2015

Cardiomyocyte-specific Loss of Diacylglycerol Acyltransferase 1 (DGAT1) Reproduces the Abnormalities in Lipids Found in Severe Heart Failure

Liu, Li; Trent, Chad M.; Fang, Xiang; Son, Ni-Huiping et al.

Ingår i Journal of Biological Chemistry, s. 29881-29891, 2014

• DOI för Cardiomyocyte-specific Loss of Diacylglycerol Acyltransferase 1 (DGAT1) Reproduces the Abnormalities in Lipids Found in Severe Heart Failure

Quantitative Imaging of Serotonergic Biosynthesis and Degradation in the Endocrine Pancreas

Eriksson, Olof; Selvaraju, Ram K; Johansson, Lars; Eriksson, Jan W et al.

Ingår i Journal of Nuclear Medicine, s. 460-465, 2014

• DOI för Quantitative Imaging of Serotonergic Biosynthesis and Degradation in the Endocrine Pancreas

The Positron Emission Tomography ligand [11C]5-Hydroxy-Tryptophan can be used as a surrogate marker for the human endocrine pancreas

Eriksson, Olof; Espes, Daniel; Selvaraju, Ram K; Jansson, Emma et al.

Ingår i Diabetes, s. 3428-3437, 2014

• DOI för The Positron Emission Tomography ligand [11C]5-Hydroxy-Tryptophan can be used as a surrogate marker for the human endocrine pancreas

Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment

Lopes, P. C.; Fuhrmann, A.; Carvalho, F.; Sereno, J. et al.

Ingår i Biochemical Pharmacology, s. 61-73, 2014

• DOI för Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment

A Case Report of Improved Metabolic Control After Conversion From Everolimus to Cyclosporin A: Role of Adipose Tissue Mechanisms?

Pereira, Maria J.; Eriksson, Jan W.; Svensson, M. K.

Ingår i Transplantation Proceedings, s. 2377-2380, 2014

• DOI för A Case Report of Improved Metabolic Control After Conversion From Everolimus to Cyclosporin A: Role of Adipose Tissue Mechanisms?

FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance

Pereira, Maria J; Palming, Jenny; Svensson, Maria K; Rizell, Magnus et al.

Ingår i Metabolism, s. 1198-1208, 2014

• DOI för FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance

Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial

Denison, H; Nilsson, C; Löfgren, L; Himmelmann, A et al.

Ingår i Diabetes, obesity and metabolism, s. 334-343, 2014

• DOI för Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial

Cannabinoid receptor type 1 expression in human adipose tissue is upregulated by glucocorticoids and is associated with insulin resistance

Sidibeh, Cherno O.; Pereira, Maria João; Hammar, M.; Katsogiannos, Petros et al.

Ingår i Diabetologia, 2014

FKBP5 gene polymorphisms and expression in human adipose tissue are associated with insulin resistance and type 2 diabetes

Pereira, Maria João; Palming, J.; Svensson, M. K.; Rizell, M. et al.

Ingår i Diabetologia, 2014

Short and long term in vivo effects of Cyclosporine A and Sirolimus on genes and proteins involved in lipid metabolism in Wistar rats

Lopes, Patricia C.; Fuhrmann, Amelia; Sereno, Jose; Espinoza, Daniel O. et al.

Ingår i Metabolism, s. 702-715, 2014

• DOI för Short and long term in vivo effects of Cyclosporine A and Sirolimus on genes and proteins involved in lipid metabolism in Wistar rats

Cyclosporine A and Tacrolimus Reduce the Amount of GLUT4 at the Cell Surface in Human Adipocytes: Increased Endocytosis as a Potential Mechanism for the Diabetogenic Effects of Immunosuppressive Agents

Pereira, Maria João; Palming, Jenny; Rizell, Magnus; Aureliano, Manuel et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, 2014

• DOI för Cyclosporine A and Tacrolimus Reduce the Amount of GLUT4 at the Cell Surface in Human Adipocytes: Increased Endocytosis as a Potential Mechanism for the Diabetogenic Effects of Immunosuppressive Agents

Assessment of beta-cell function in young patients with type 2 diabetes: arginine-stimulated insulin secretion may reflect beta-cell reserve

Sjöstrand, M; Carlson, K; Arnqvist, H J; Gudbjörnsdottir, S et al.

Ingår i Journal of Internal Medicine, s. 39-48, 2014

Pharmacodynamic effects of the oral glucokinase activator AZD6370 after single doses in healthy volunteers assessed with euglycaemic clamp

Sjöstrand, M; Ericsson, H; Hartford, M; Norjavaara, E et al.

Ingår i Diabetes, obesity and metabolism, s. 35-41, 2013

• DOI för Pharmacodynamic effects of the oral glucokinase activator AZD6370 after single doses in healthy volunteers assessed with euglycaemic clamp

Cyclosporin A and tacrolimus impair dynamics of GLUT4 traffic in insulin-responsive cells

Pereira, Maria João; Palming, J.; Rizell, M.; Aureliano, M. et al.

Ingår i Diabetologia, 2013

Variability in fasting lipid and glycogen contents in hepatic and skeletal muscle tissue in subjects with and without type 2 diabetes: a ¹H and ¹³C MRS study

Stephenson, M C; Leverton, E; Khoo, E Y H; Poucher, S M et al.

Ingår i NMR in Biomedicine, s. 1518-1526, 2013

• DOI för Variability in fasting lipid and glycogen contents in hepatic and skeletal muscle tissue in subjects with and without type 2 diabetes: a ¹H and ¹³C MRS study

Differences between men and women in the regulation of adipose 11β-HSD1 and in its association with adiposity and insulin resistance

deSchoolmeester, J; Palming, J; Persson, T; Pereira, Maria J et al.

Ingår i Diabetes, obesity and metabolism, s. 1056-1560, 2013

• DOI för Differences between men and women in the regulation of adipose 11β-HSD1 and in its association with adiposity and insulin resistance

A one-week phase 1 trial with the DGAT1 inhibitor AZD7687: lipid handling, hormone secretion and adverse effects in the gut

Denison, H.; Nilsson, C.; Lofgren, L.; Al-Shurbaji, A. et al.

Ingår i Diabetologia, 2013

Increased insulin secretion and decreased glucose concentrations, but not allostatic load, are associated with stress-related exhaustion in a clinical patient population

Sjörs, A; Jansson, P-A; Eriksson, Jan W; Jonsdottir, I H

Ingår i Stress, s. 24-33, 2013

• DOI för Increased insulin secretion and decreased glucose concentrations, but not allostatic load, are associated with stress-related exhaustion in a clinical patient population

The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue

Pereira, Maria J; Palming, Jenny; Rizell, Magnus; Aureliano, Manuel et al.

Ingår i Molecular and Cellular Endocrinology, s. 260-269, 2013

• DOI för The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue

Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study

Denison, H; Nilsson, C; Kujacic, M; Löfgren, L et al.

Ingår i Diabetes, obesity and metabolism, s. 136-143, 2013

• DOI för Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study

Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study

Hernestål-Boman, Jenny; Norberg, Margareta; Jansson, Jan-Hakan; Eliasson, Mats et al.

Ingår i Cardiovascular Diabetology, s. 152, 2012

• DOI för Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study

Novel pancreatic beta cell-specific proteins: Antibody-based proteomics for identification of new biomarker candidates

Lindskog, Cecilia; Korsgren, Olle; Pontén, Fredrik; Eriksson, Jan W et al.

Ingår i Journal of Proteomics, s. 2611-2620, 2012

• DOI för Novel pancreatic beta cell-specific proteins: Antibody-based proteomics for identification of new biomarker candidates

Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687)

Barlind, Jonas G; Bauer, Udo A; Birch, Alan M; Birtles, Susan et al.

Ingår i Journal of Medicinal Chemistry, s. 10610-10629, 2012

• DOI för Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687)

Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus

Ruge, Toralph; Sukonina, Valentina; Kroupa, Olessia; Makoveichuk, Elena et al.

Ingår i Metabolism, s. 652-660, 2012

• DOI för Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus

Elevation of alanine transaminase and markers of liver fibrosis after a mixed meal challenge in individuals with type 2 diabetes

Khoo, E Y H; Stevenson, M C; Leverton, E; Cross, R et al.

Ingår i Digestive Diseases and Sciences, s. 3017-3025, 2012

• DOI för Elevation of alanine transaminase and markers of liver fibrosis after a mixed meal challenge in individuals with type 2 diabetes

mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes

Pereira, Maria J; Palming, Jenny; Rizell, Magnus; Aureliano, Manuel et al.

Ingår i Molecular and Cellular Endocrinology, s. 96-105, 2012

• DOI för mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes

Increased Urine IgM and IgG₂ Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes

Torffvit, Ole; Kalani, Majid; Apelqvist, Jan; Eliasson, Björn et al.

Ingår i Biochemistry Research International, s. 480529, 2012

• DOI för Increased Urine IgM and IgG₂ Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes

Hydrochlorothiazide Compared to Candesartan Treatment Increases Adipose Tissue Gene Expression and Circulating Levels of Serum Amyloid A in Hypertensive Patients

Palming, J.; Jansson, P-A; Renström, F.; Johansson, A. et al.

Ingår i Hormone and Metabolic Research, s. 319-324, 2011

• DOI för Hydrochlorothiazide Compared to Candesartan Treatment Increases Adipose Tissue Gene Expression and Circulating Levels of Serum Amyloid A in Hypertensive Patients

Effects of adrenaline on whole-body glucose metabolism and insulin-mediated regulation of glycogen synthase and PKB phosphorylation in human skeletal muscle

Jensen, Jørgen; Ruge, Toralph; Lai, Yu-Chiang; Svensson, Maria K et al.

Ingår i Metabolism, s. 215-226, 2011

• DOI för Effects of adrenaline on whole-body glucose metabolism and insulin-mediated regulation of glycogen synthase and PKB phosphorylation in human skeletal muscle

DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle

Liu, Li; Yu, Shuiqing; Khan, Raffay S; Ables, Gene P et al.

Ingår i Journal of Lipid Research, s. 732-744, 2011

• DOI för DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle

Change in the amount of body fat and IL-6 levels is related to altered insulin sensitivity in type 1 diabetes patients with or without diabetic nephropathy

Svensson, M K; Eriksson, Jan W

Ingår i Hormone and Metabolic Research, s. 209-215, 2011

• DOI för Change in the amount of body fat and IL-6 levels is related to altered insulin sensitivity in type 1 diabetes patients with or without diabetic nephropathy

Atropine improves insulin sensitivity in both lean and abdominally obese subjects

Svensson, M K; Jansson, P-A; Persson, A L; Sjöstrand, M et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, 2011

• DOI för Atropine improves insulin sensitivity in both lean and abdominally obese subjects

Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk

Handberg, A; Norberg, M; Stenlund, H; Hallmans, G et al.

Ingår i Journal of Clinical Endocrinology and Metabolism, s. 1939-1946, 2010

• DOI för Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk

Repeated measurements of 11β-HSD-1 activity in subcutaneous adipose tissue from lean, abdominally obese, and type 2 diabetes subjects: no change following a mixed meal

Sjöstrand, M; Jansson, P-A; Palming, J; de Schoolmeester, J et al.

Ingår i Hormone and Metabolic Research, s. 798-802, 2010

• DOI för Repeated measurements of 11β-HSD-1 activity in subcutaneous adipose tissue from lean, abdominally obese, and type 2 diabetes subjects: no change following a mixed meal

Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes

Pereira, Maria João; Carvalho, Eugénia; Eriksson, Jan W; Crans, Debbie C et al.

Ingår i Journal of Inorganic Biochemistry, s. 1687-1692, 2009

• DOI för Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes

Factors in serum from type 2 diabetes patients can cause cellular insulin resistance

Renström, F; Burén, J; Svensson, M K; Eriksson, Jan W

Ingår i Hormone and Metabolic Research, s. 767-772, 2009

• DOI för Factors in serum from type 2 diabetes patients can cause cellular insulin resistance

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone

Newcomer, John W; Ratner, Robert E; Eriksson, Jan W; Emsley, Robin et al.

Ingår i Journal of Clinical Psychiatry, s. 487-499, 2009

Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index

Ruge, Toralph; Lockton, J Andrew; Renstrom, Frida; Lystig, Theodore et al.

Ingår i Metabolism, s. 860-866, 2009

• DOI för Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index

Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes

Sahli, David; Eriksson, Jan W; Boman, Kurt; Svensson, Maria K

Ingår i Thrombosis Research, s. 701-706, 2009

• DOI för Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes

Association of serum amyloid A levels with adipocyte size and serum levels of adipokines: differences between men and women

Sjöholm, Kajsa; Lundgren, Magdalena; Olsson, Maja; Eriksson, Jan W

Ingår i Cytokine, s. 260-266, 2009

• DOI för Association of serum amyloid A levels with adipocyte size and serum levels of adipokines: differences between men and women

Neuroendocrine mechanisms in insulin resistance

Sjöstrand, Mikaela; Eriksson, Jan W

Ingår i Molecular and Cellular Endocrinology, s. 104-111, 2009

• DOI för Neuroendocrine mechanisms in insulin resistance

Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study

Eriksson, Jan W.; Jansson, Per-Anders; Carlberg, Bo; Hägg, Anders et al.

Ingår i Hypertension, s. 1030-1037, 2008

• DOI för Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study

Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus

Krachler, Benno; Norberg, Margareta; Eriksson, Jan W; Hallmans, Göran et al.

Ingår i NMCD. Nutrition Metabolism and Cardiovascular Diseases, s. 503-10, 2008

• DOI för Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus

The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk

Möllsten, Anna; Kockum, Ingrid; Svensson, Maria; Rudberg, Susanne et al.

Ingår i Journal of diabetes and its complications, s. 377-383, 2008

• DOI för The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk

Replik om nya läkemedel mot typ 2-diabetes: Viktigt att vi skaffar oss erfarenhet och kunskap

Sjöholm, Åke; Agardh, Carl-David; Brismar, Kerstin; Efendic, Suad et al.

Ingår i Läkartidningen, 2008

Bättre mäta tåblodtryck än ankelblodtryck hos patienter med diabetes

Svensson, Maria K; Eriksson, Jan W

Ingår i Läkartidningen, s. 925-926, 2008

Insulin action and signalling in fat and muscle from dexamethasone-treated rats

Burén, J; Lai, Y C; Lundgren, M; Eriksson, Jan W et al.

Ingår i Archives of Biochemistry and Biophysics, s. 91-101, 2008

• DOI för Insulin action and signalling in fat and muscle from dexamethasone-treated rats

Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients

Bakhtadze, E; Cervin, C; Lindholm, E; Borg, H et al.

Ingår i Diabetologia, s. 2224-2232, 2008

• DOI för Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients

Sex- and depot-specific lipolysis regulation in human adipocytes: interplay between adrenergic stimulation and glucocorticoids

Lundgren, M; Burén, J; Lindgren, P; Myrnäs, T et al.

Ingår i Hormone and Metabolic Research, s. 854-860, 2008

• DOI för Sex- and depot-specific lipolysis regulation in human adipocytes: interplay between adrenergic stimulation and glucocorticoids

Ketoacidosis occurs in both Type 1 and Type 2 diabetes: a population-based study from Northern Sweden

Wang, Z H; Kihl-Selstam, E; Eriksson, Jan W

Ingår i Diabetic Medicine, s. 867-870, 2008

• DOI för Ketoacidosis occurs in both Type 1 and Type 2 diabetes: a population-based study from Northern Sweden

Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes.

Renström, Frida; Burén, Jonas; Svensson, Maria; Eriksson, Jan W

Ingår i Metabolism, s. 190-8, 2007

• DOI för Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes.

Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.

Lundgren, M; Svensson, M; Lindmark, S; Renström, F et al.

Ingår i Diabetologia, s. 625-33, 2007

• DOI för Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.

Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.

Kalani, Majid; Silveira, Angela; Blombäck, Margareta; Apelqvist, Jan et al.

Ingår i Thrombosis Research, s. 653-61, 2007

• DOI för Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.

Work stress and low emotional support is associated with increased risk of future type 2 diabetes in women.

Norberg, M; Stenlund, H; Lindahl, B; Andersson, C et al.

Ingår i Diabetes Research and Clinical Practice, s. 368-77, 2007

• DOI för Work stress and low emotional support is associated with increased risk of future type 2 diabetes in women.

Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance.

Eriksson, Jan W

Ingår i FEBS Letters, s. 3734-42, 2007

• DOI för Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance.

Components of metabolic syndrome predicting diabetes: no role of inflammation or dyslipidemia.

Norberg, Margareta; Stenlund, Hans; Lindahl, Bernt; Andersson, Christer et al.

Ingår i Obesity, s. 1875-85, 2007

• DOI för Components of metabolic syndrome predicting diabetes: no role of inflammation or dyslipidemia.

Short-term effects of metformin in type 2 diabetes

Eriksson, A.; Attvall, S.; Bonnier, M.; Eriksson, Jan W. et al.

Ingår i Diabetes, obesity and metabolism, s. 330-336, 2007

• DOI för Short-term effects of metformin in type 2 diabetes

Metabolic syndrome: psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes

Abraham, N G; Brunner, E J; Eriksson, J W; Robertson, R P

Ingår i Annals of the New York Academy of Sciences, s. 256-275, 2007

• DOI för Metabolic syndrome: psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes

Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden.

Torffvit, Ole; Eriksson, Jan W; Henricsson, Marianne; Sundkvist, Göran et al.

Ingår i Journal of diabetes and its complications, s. 246-51, 2007

• DOI för Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden.

Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS)

Littorin, Bengt; Blom, P.; Schölin, Anna; Arnqvist, H. J. et al.

Ingår i Diabetologia, s. 2847-2852, 2006

• DOI för Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS)

Insulin resistance in diabetic nephropathy - cause or consequence?

Svensson, Maria; Eriksson, Jan W

Ingår i Diabetes/Metabolism Research Reviews, s. 401-410, 2006

• DOI för Insulin resistance in diabetic nephropathy - cause or consequence?

HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden

Bakhtadze, E; Borg, H; Stenström, G; Fernlund, P et al.

Ingår i Diabetologia, s. 1785-1794, 2006

• DOI för HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden

Is insulin resistance caused by defects in insulin's target cells or by a stressed mind?

Burén, Jonas; Eriksson, Jan W

Ingår i Diabetes/Metabolism Research Reviews, s. 487-94, 2005

• DOI för Is insulin resistance caused by defects in insulin's target cells or by a stressed mind?

Assessment of toe blood pressure is an effective screening method to identify diabetes patients with lower extremity arterial disease.

Sahli, David; Eliasson, Björn; Svensson, Maria; Blohmé, Göran et al.

Ingår i Angiology, s. 641-51, 2004

Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes

Schölin, Anna; Törn, C; Nyström, L; Berne, Christian et al.

Ingår i Diabetic Medicine, s. 447-455, 2004

• DOI för Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes

Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden

Schölin, Anna; Björklund, L; Borg, H; Arnqvist, H et al.

Ingår i Journal of Internal Medicine, s. 384-391, 2004

• DOI för Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden

No direct link between albumin excretion rate and insulin resistance: A study in type 1 diabetes patients with mild nephropathy

Svensson, Maria; Eriksson, Jan W

Ingår i Hormone and Metabolic Research, s. 254-259, 2002

• DOI för No direct link between albumin excretion rate and insulin resistance: A study in type 1 diabetes patients with mild nephropathy

Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment: A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes

Littorin, B; Sundkvist, G; Hagopian, W; Landin-Olsson, M et al.

Ingår i Diabetes Care, s. 409-412, 1999

• DOI för Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment: A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes

Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance: a case report

Eriksson, Jan W; Bremell, T; Eliasson, B; Fowelin, J et al.

Ingår i Diabetes Care, s. 1217-1220, 1998

Insulin promotes and cyclic adenosine 3',5'-monophosphate impairs functional insertion of insulin receptors in the plasma membrane of rat adipocytes: evidence for opposing effects of tyrosine and serine/threonine phosphorylation

Eriksson, Jan W; Lönnroth, P; Wesslau, C; Smith, U

Ingår i Endocrinology, s. 607-612, 1997

• DOI för Insulin promotes and cyclic adenosine 3',5'-monophosphate impairs functional insertion of insulin receptors in the plasma membrane of rat adipocytes: evidence for opposing effects of tyrosine and serine/threonine phosphorylation

Fallbeskrivning: inhalationssteroider gav binjurebarkshämning

Rask, E; Eriksson, Jan W; Forsberg, G

Ingår i Läkartidningen, s. 3529-3530, 3533, 1997

Is hyperinsulinemia the cause of acanthosis nigricans in the type B syndrome of insulin resistance?

Eriksson, Jan W

Ingår i Diabetes Care, s. 1045-1045, 1997

• DOI för Is hyperinsulinemia the cause of acanthosis nigricans in the type B syndrome of insulin resistance?

Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation

Yu, Z W; Jansson, P A; Posner, B I; Smith, U et al.

Ingår i Diabetologia, s. 1197-1203, 1997

• DOI för Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation

A new non-invasive method using pulse oximetry for the assessment of arterial toe pressure

Samuelsson, P; Blohmé, G; Fowelin, J; Eriksson, Jan W

Ingår i Clinical Physiology, s. 463-467, 1996

Effects of peroxovanadate and vanadate on insulin binding, degradation and sensitivity in rat adipocytes

Yu, Z W; Posner, B I; Smith, U; Eriksson, Jan W

Ingår i Biochimica et Biophysica Acta, s. 103-109, 1996

A stable peroxovanadium compound with insulin-like action in human fat cells

Eriksson, Jan W; Lönnroth, P; Posner, B I; Shaver, A et al.

Ingår i Diabetologia, s. 235-242, 1996

• DOI för A stable peroxovanadium compound with insulin-like action in human fat cells

Cryptic receptors for insulin-like growth factor II in the plasma membrane of rat adipocytes: a possible link to cellular insulin resistance

Yu, Z W; Wickman, A; Eriksson, Jan W

Ingår i Biochimica et Biophysica Acta, s. 57-62, 1996

Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients

Eriksson, Jan W.; Jansson, Per-Anders; Foley, Karen; Lithell, Hans

Ingår i Journal of Hypertension, s. 1469-1475, 1996

Syndrom med svår insulinresistens: sällsynta tillstånd men viktiga att identifiera

Eriksson, Jan W; Wiberg, K; Yu, Z W; Tarkowski, A et al.

Ingår i Läkartidningen, s. 2917-2923, 1995

The cGMP-inhibitable phosphodiesterase modulates glucose transport activation by insulin

Eriksson, Jan W; Wesslau, C; Smith, U

Ingår i Biochimica et Biophysica Acta, s. 163-167, 1994

Insulin concentrations and insulin sensitivity after short-term amiloride in healthy subjects

Eriksson, Jan W; Fowelin, J; Urbanavicius, V

Ingår i European Journal of Clinical Pharmacology, s. 469-472, 1994

• DOI för Insulin concentrations and insulin sensitivity after short-term amiloride in healthy subjects

Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes

Lönnroth, P; Eriksson, Jan W; Posner, B I; Smith, U

Ingår i Diabetologia, s. 113-116, 1993

• DOI för Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes

Cellular cyclic AMP levels modulate insulin sensitivity and responsiveness: evidence against a significant role of Gi in insulin signal transduction

Wesslau, C; Eriksson, Jan W; Smith, U

Ingår i Biochemical and Biophysical Research Communications - BBRC, s. 287-293, 1993

• DOI för Cellular cyclic AMP levels modulate insulin sensitivity and responsiveness: evidence against a significant role of Gi in insulin signal transduction

Cyclic AMP impairs the rapid effect of insulin to enhance cell-surface insulin-binding capacity in rat adipocytes

Eriksson, Jan W; Lönnroth, P; Smith, U

Ingår i Biochemical Journal, s. 625-629, 1992

Vanadate increases cell surface insulin binding and improves insulin sensitivity in both normal and insulin-resistant rat adipocytes

Eriksson, Jan W; Lönnroth, P; Smith, U

Ingår i Diabetologia, s. 510-516, 1992

Remaning β-cell function eight years after diagnosis of autoimmune diabetes in young adults.: Relation to islet antibodies and clinical features

Schölin, Anna; Björklund, Linda; Borg, Henrik; Arnqvist, Hans et al.

BMI, ketoacidosis and GADA are important factors for prediction of remission in type 1 diabetes

Schölin, Anna; Törn, Carina; Arnqvist, Hans; Berne, Christian et al.

Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?

Eriksson, Jan W.; Eliasson, Björn; Bennet, Louise; Sundström, Johan

Ingår i Diabetologia, s. 1575-1586, 2022

• DOI för Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?
• Ladda ner fulltext (pdf) av Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?

Metformin as an anti-inflammatory agent: a short review

Kristofi, Robin; Eriksson, Jan W.

Ingår i Journal of Endocrinology, 2021

• DOI för Metformin as an anti-inflammatory agent: a short review

Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes?

Lundqvist, Martin H.; Almby, Kristina E.; Abrahamsson, Niclas; Eriksson, Jan

Ingår i Frontiers in Physiology, 2019

• DOI för Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes?
• Ladda ner fulltext (pdf) av Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes?

THE PLASMA METABOLOMIC PROFILE IS DIFFERENTLY ASSOCIATED WITH LIVER FAT, VISCERAL ADIPOSE TISSUE AND PANCREATIC FAT: Supplementary Table 1.

Lind, Lars; Salihovic, Samira; Risérus, Ulf; Kullberg, Joel et al.

2020

Integration of whole-body PET/MRI with non-targeted metabolomics provides new insights into insulin sensitivity of various tissues

Diamanti, Klev; Visvanathar, Robin; Pereira, Maria J; Cavalli, Marco et al.

Role of glucocorticoids in adipose tissue fibrosis and interplay between macrophages and adipose cells

Sarsenbayeva, Assel; Pereira, Maria J.; Ahmed, Fozia; Dipta, Priya et al.

Exploration of whole-body PET/MRI and clinical variables in type 2 diabetes for data-driven hypothesis generation

Visvanathar, Robin; Carlbom, Lina; Ekström, Simon; Strand, Robin et al.

Early hormonal adaptations to weight loss: Responses to an oral glucose load following obesity surgery and low-energy diet

Fanni, Giovanni; Hukema, Fleur; Hetty, Susanne; Sundbom, Magnus et al.